Het geheim achter topklinische kwaliteit

Knieschijf: Kniespecialist RPA Janssen is topspecialist in de behandeling van knieschijfklachten. meniscushechting zeker mogelijk bij sporters
Lees meer →

Benoeming Lectoraat Value-Based Health Care

Dr. RPA Janssen is per...

Lees meer →

Gastspreker Onderzoek in Beweging 2019 UM

Dr. RPA Janssen is...

Lees meer →

Interview Nieuwjaarsontmoeting Gemeente Veldhoven

Dr. RPA Janssen is uitgenodigd voor...

Volg mij!

Volg gratis de wetenschappelijke ontwikkelingen over de knie via Facebook, Twitter en andere netwerken!

Culturing human osteoarthritic osteochondral explants

Culturing human osteoarthritic osteochondral explants

Meike W.A. Kleuskens, (René) C.C. van Donkelaar, Rob P.A. Janssen and Keita Ito

Current knee osteoarthritis (OA) treatments are sub-optimal and not long-lasting. Within the osteoarthritis moonshot, osteochondral implants for focal cartilage defects are developed which need to regenerate cartilage and bone and integrate with the adjacent tissues. The challenge is to explore and optimize this in an in vitrosetting, to identify the most promising implants for the ultimate animal studies. This may be done by inserting the implant in an osteochondral defect that is created in an osteochondral explant in culture. To do so, it is necessary to first demonstrate that an osteochondral explant can be kept in culture for a longer time while preserving its properties and composition. Aim of the present study is therefore to characterize human osteochondral tissue at various stages of OA, and to develop an approach to culture OA tissue for 28 days. 

Osteochondral explants (Ø10mm) with either a smooth or fibrillated cartilage surface, representing different OA stages, were harvested from human tibia plateaus obtained from total knee replacement surgeries at the Maxima Medical Centre, Eindhoven and were cultured in a double-chamber culture platform (figure 1).[1]Fresh and cultured explants were evaluated for their viability, biochemical tissue content and cellular gene expression. Moreover, sections were stained with safranin-O/fast green for analysis of the proteoglycan and collagen distribution and to determine the grade of OA using the Mankin scoring system.[2]

Statistical differences between smooth and fibrillated cartilage were found in biochemical and histological analyses of fresh cartilage (average Mankin score of 3.4 vs. 5.1, proteoglycan content of 8.4 ± 1.7%dwvs. 13.5 ± 3.2%dw, collagen content of 39.9 ± 3.8%dwvs. 29.3 ± 4.6%dwrespectively). Preliminary results of the cultures reveal that chondrocyte viability was maintained over 28 days, but bone tissue was less viable. Analysis of the cultured samples is ongoing to explore whether the biochemical and histological composition of the cartilage is preserved over time. 


[1]Andrea Schwab and others, ‘Ex Vivo Culture Platform for Assessment of Cartilage Repair Treatment Strategies’, Altex, 34.2 (2017), 267–77 <https://doi.org/10.14573/altex.1607111>.

[2]H J Mankin and others, ‘Biochemical and Metabolic Abnormalities in Articular Cartilage from Osteo-Arthritic Human Hips. II. Correlation of Morphology with Biochemical and Metabolic Data.’, The Journal of Bone and Joint Surgery. American Volume, 53.3 (1971), 523–37.

← Terug naar het publicatie-overzicht


Dr. RPA Janssen
RPA Janssen Orthopedie B.V.
Coöperatie Orthopedie Groot Eindhoven
Orthopedisch Centrum Máxima
Máxima Medisch Centrum (MMC)

Bezoekadres MMC Eindhoven:
Ds. Th. Fliednerstraat 1
Ingang Zuid
5631 BM  Eindhoven
(Spreekuur en operaties)

Bezoekadres MMC Veldhoven:
De Run 4600
5504 DB  Veldhoven

Postbus 90052
5600 PD  Eindhoven

Tel.: 040 88 88 600
(Afspraken bureau Orthopedie)

Fax: 040 88 85 938

Externe bronnen:
Cooperatie Orthopedie Groot Eindhoven
Máxima Medisch Centrum
Orthopedisch Centrum Máxima
Sportklinisch Expertisecentrum
FC Kruisband
Nicky van Melick

RPA Janssen op YouTube
RPA Janssen op Twitter
RPA Janssen op Facebook
RPA Janssen op LinkedIn
RPA Janssen weblog